The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis
Abstract
IMPORTANCE: Primary tumor location is emerging as an important prognostic factor owing to distinct biological features. However, the side of origin of colon cancer (CC) still does not represent a prognostic parameter when deciding for adjuvant or palliative chemotherapy. OBJECTIVE: To determine the prognostic role of left vs right-sidedness of primary tumor location in patients with CC. DATA SOURCES: We searched PubMed, EMBASE, The Cochrane Library, Web of Science, LILACS, CINAHL, and SCOPUS for prospective or retrospective studies reporting data on overall survival for left-sided colon cancer (LCC) compared with right-sided colon cancer (RCC). STUDY SELECTION: Studies were selected if: (1) side of CC was reported among variables entered into survival analysis, (2) survival information was available (overall survival [OS] was reported in the article as hazard ratio (HR) according to multivariate analysis, (3) articles were published in the English language. DATA EXTRACTION AND SYNTHESIS: Data were pooled using HRs for OS of LCC vs RCC according to fixed or random-effects models. Subgroup analysis and multivariate random-effects model meta-regression was also implemented adjusting for stage distribution, sample size, race, year of publication, type and quality of studies, and adjuvant chemotherapy. MAIN OUTCOMES AND MEASURES: HRs for OS (the primary outcome measure) were pooled to provide an aggregate value. In this analysis, all HRs with 95% CIs were pooled to obtain prognostic information on the location of the primary tumor (left vs right location site of CC) independent of other common clinicopathological covariates. RESULTS: An analysis was made from the 66 studies conducted. It included 1 437 846 patients with a median follow-up of 65 months. Left sided primary tumor location was associated with a significantly reduced risk of death (HR, 0.82; 95% CI, 0.79-0.84; P < .001) and this was independent of stage, race, adjuvant chemotherapy, year of study, number of participants, and quality of included studies. CONCLUSIONS AND RELEVANCE: Based on these results, CC side should be acknowledged as a criterion for establishing prognosis in all stages of disease. It should be considered when deciding treatment intensity in metastatic settings, and should represent a stratification factor for future adjuvant studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Hohenberger, W., Weber, K., Matzel, K., Papadopoulos, T., & Merkel, S. (2009) · Colorectal Disease · doi:10.1111/j.1463-1318.2008.01735.x · Cited by 1,636
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Loupakis, F., Cremolini, C., Masi, G., Lonardi, S., Zagonel, V., Salvatore, L., Cortesi, E., Tomasello, G., Ronzoni, M., Spadi, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403108 · Cited by 1,062
Self-citationTran, B., Kopetz, S., Tie, J., Gibbs, P., Jiang, Z., Lieu, C. H., Agarwal, A., Maru, D. M., Sieber, O., & Desai, J. (2011) · Cancer · doi:10.1002/cncr.26086 · Cited by 797
Are there two sides to colorectal cancer?
Iacopetta, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10635 · Cited by 782
Bufill, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-10-779 · Cited by 722
André, T., de Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4238 · Cited by 683
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
Is There a Difference in Survival between Right- versus Left-Sided Colon Cancers?
Meguid, R. A., Slidell, M. B., Wolfgang, C. L., Chang, D. C., & Ahuja, N. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0015-y · Cited by 546
Pietrantonio, F., Petrelli, F., Coinu, A., Di Bartolomeo, M., Borgonovo, K., Maggi, C., Cabiddu, M., Iacovelli, R., Bossi, I., Lonati, V., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.01.054 · Cited by 486
Self-citationBertelsen, C. A., Neuenschwander, A. U., Jansen, J. E., Wilhelmsen, M., Kirkegaard-Klitbo, A., Tenma, J. R., Bols, B., Ingeholm, P., Rasmussen, L. A., Jepsen, L. V., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71168-4 · Cited by 485
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
Loupakis, F., Yang, D., Yau, L., Feng, S., Cremolini, C., Zhang, W., Maus, M. K. H., Antoniotti, C., Langer, C., Scherer, S. J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju427 · Cited by 472
Weiss, J. M., Pfau, P. R., O'Connor, E. S., King, J., LoConte, N., Kennedy, G., & Smith, M. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4414 · Cited by 412
Johnson, P. M., Porter, G. A., Ricciardi, R., & Baxter, N. N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8866 · Cited by 358
Venook, A. P., Niedzwiecki, D., Innocenti, F., Fruth, B., Greene, C., O'Neil, B. H., Shaw, J. E., Atkins, J. N., Horvath, L. E., Polite, B. N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.3504 · Cited by 336
Brulé, S. Y., Jonker, D. J., Karapetis, C. S., O’Callaghan, C. J., Moore, M. J., Wong, R., Tebbutt, N. C., Underhill, C., Yip, D., Zalcberg, J. R., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.03.015 · Cited by 332
Sinicrope, F. A., Mahoney, M. R., Smyrk, T. C., Thibodeau, S. N., Warren, R. S., Bertagnolli, M. M., Nelson, G. D., Goldberg, R. M., Sargent, D. J., & Alberts, S. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9591 · Cited by 279
Fariña-Sarasqueta, A., van Lijnschoten, G., Moerland, E., Creemers, G.-J., Lemmens, V. E. P. P., Rutten, H. J. T., & van den Brule, A. J. C. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq258 · Cited by 263
Søndenaa, K., Quirke, P., Hohenberger, W., Sugihara, K., Kobayashi, H., Kessler, H., Brown, G., Tudyka, V., D’Hoore, A., Kennedy, R. H., et al. (2014) · International Journal of Colorectal Disease · doi:10.1007/s00384-013-1818-2 · Cited by 224
Shen, H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i21.6470 · Cited by 214
Lanza, G., Gafà, R., Santini, A., Maestri, I., Guerzoni, L., & Cavazzini, L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2433 · Cited by 210
Ward, R. L., Cheong, K., Ku, S.-L., Meagher, A., O’Connor, T., & Hawkins, N. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.123 · Cited by 193
Merok, M. A., Ahlquist, T., Røyrvik, E. C., Tufteland, K. F., Hektoen, M., Sjo, O. H., Mala, T., Svindland, A., Lothe, R. A., & Nesbakken, A. (2013) · Annals of Oncology · doi:10.1093/annonc/mds614 · Cited by 190
Breivik, J., Lothe, R. A., Meling, G. I., Rognum, T. O., Børresen-Dale, A.-L., & Gaudernack, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971219)74:6<664::aid-ijc18>3.0.co;2-5 · Cited by 181
Cremolini, C., Bartolomeo, M. D., Amatu, A., Antoniotti, C., Moretto, R., Berenato, R., Perrone, F., Tamborini, E., Aprile, G., Lonardi, S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv290 · Cited by 173
Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
Price, T. J., Beeke, C., Ullah, S., Padbury, R., Maddern, G., Roder, D., Townsend, A. R., Moore, J., Roy, A., Tomita, Y., et al. (2015) · Cancer · doi:10.1002/cncr.29129 · Cited by 170
Kalady, M. F., DeJulius, K. L., Sanchez, J. A., Jarrar, A., Liu, X., Manilich, E., Skacel, M., & Church, J. M. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31823c08b3 · Cited by 163
Negri, F., Wotherspoon, A. C., Cunningham, D., Norman, A. R., Chong, G., & Ross, P. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi244 · Cited by 161
Mucinous adenocarcinomas: Poor prognosis in metastatic colorectal cancer
Mekenkamp, L. J. M., Heesterbeek, K. J., Koopman, M., Tol, J., Teerenstra, S., Venderbosch, S., Punt, C. J. A., & Nagtegaal, I. D. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.004 · Cited by 159
Selby, W. S., Janossy, G., & Jewell, D. P. (1981) · Gut · doi:10.1136/gut.22.3.169 · Cited by 149
Miyamoto, Y., Baba, Y., Sakamoto, Y., Ohuchi, M., Tokunaga, R., Kurashige, J., Hiyoshi, Y., Iwagami, S., Yoshida, N., Watanabe, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129742 · Cited by 147
Tarantino, I., Warschkow, R., Worni, M., Cerny, T., Ulrich, A. B., Schmied, B. M., & Güller, U. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000860 · Cited by 140
Are Right- and Left-Sided Colon Neoplasms Distinct Tumors?
Distler, P., & Holt, P. R. (2008) · Digestive Diseases · doi:10.1159/000171605 · Cited by 133
Tumor Subsite Location Within the Colon Is Prognostic for Survival After Colon Cancer Diagnosis
Wray, C. M., Ziogas, A., Hinojosa, M. W., Le, H. V., Stamos, M. J., & Zell, J. A. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181a7b7de · Cited by 131
Holleczek, B., Rossi, S., Agius, D., Innos, K., Minicozzi, P., Francisci, S., Hackl, M., Eisemann, N., Brenner, H., Hackl, M., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.024 · Cited by 127
Benedix, F., Schmidt, U., Mroczkowski, P., Gastinger, I., Lippert, H., & Kube, R. (2010) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2010.12.004 · Cited by 119
Outcome of right- and left-sided colonic and rectal cancer following surgical resection
Suttie, S. A., Shaikh, I., Mullen, R. E., Amin, A. I., Daniel, T., & Yalamarthi, S. (2010) · Colorectal Disease · doi:10.1111/j.1463-1318.2010.02356.x · Cited by 104
Jess, P., Hansen, I. O., Gamborg, M., & Jess, T. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002608 · Cited by 102
Selection for surgery and survival of synchronous colorectal liver metastases; a nationwide study
Norén, A., Eriksson, H. G., & Olsson, L. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.10.055 · Cited by 94
Oue, N., Anami, K., Schetter, A. J., Moehler, M. H., Okayama, H., Ma, K., Bowman, E. D., Mueller, A., Schad, A., Shimomura, M., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28522 · Cited by 93
Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer
Magnusson, C., Mezhybovska, M., Lörinc, E., Fernebro, E., Nilbert, M. C., & Sjölander, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.022 · Cited by 93
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
Boisen, M. K., Johansen, J. S., Dehlendorff, C., Larsen, J. S., Østerlind, K., Hansen, J., Nielsen, S. E., Pfeiffer, P., Tarpgaard, L. S., Holländer, N. H., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt253 · Cited by 92
Improved Survival in Young Women With Colorectal Cancer
Koo, J. H., Jalaludin, B. B., Wong, S. K. C., Kneebone, A. B., Connor, S. J., & Leong, R. W. L. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01779.x · Cited by 91
The relationship between primary tumor sidedness and prognosis in colorectal cancer.
Schrag, D., Weng, S., Brooks, G. A., Meyerhardt, J. A., & Venook, A. P. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.3505 · Cited by 84
Moritani, K., Hasegawa, H., Okabayashi, K., Ishii, Y., Endo, T., & Kitagawa, Y. (2014) · Surgery Today · doi:10.1007/s00595-013-0748-5 · Cited by 83
ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer
Renfro, L. A., Grothey, A., Xue, Y., Saltz, L. B., André, T., Twelves, C. J., Labianca, R., Allegra, C. J., Alberts, S. R., Loprinzi, C. L., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju333 · Cited by 83
Lykke, J., Roikjær, O., Jess, P., & The Danish Colorectal Cancer Group (2012) · Colorectal Disease · doi:10.1111/codi.12059 · Cited by 82
Horst, D. A., Kriegl, L., Engel, J., Jung, A., & Kirchner, T. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.004 · Cited by 74
Liang, J., Huang, K., Cheng, Y., Hsu, H., Cheng, A., Hsu, C., Yeh, K., Wang, S., & Chang, K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1637 · Cited by 73
Gleisner, A., Mogal, H., Dodson, R. M., Efron, J., Gearhart, S. L., Wick, E., Lidor, A. O., Herman, J. M., & Pawlik, T. M. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.07.404 · Cited by 70
Teixeira, M. C., Marques, D. F., Ferrari, A., Alves, M. F. S., Alex, A. K., Sabbaga, J., Hoff, P. M., & Riechelmann, R. P. (2014) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2014.09.010 · Cited by 68
Glutathione S-transferase pi in colorectal tumors is predictive for overall survival.
MULDER, T. P. J., Verspaget, H. W., Sier, C. F. M., Roelofs, H. M. J., Ganesh, S., Griffioen, G. G., & Peters, W. H. M. (1995) · PubMed · Cited by 65
Pectasides, D. G., Karavasilis, V., Papaxoinis, G., Gourgioti, G., Makatsoris, T., Raptou, G., Vrettou, E., Sgouros, J., Samantas, E., Basdanis, G., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1406-7 · Cited by 58
Sinicrope, F. A., Foster, N. R., Yoon, H. H., Smyrk, T. C., Kim, G. P., Allegra, C. J., Yothers, G., Nikcevich, D. A., & Sargent, D. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.2563 · Cited by 53
Heinemann, V., Modest, D. P., von Weikersthal, L. F., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.3600 · Cited by 53
The number of intraepithelial T cells decreases from ascending colon to rectum
Kirby, J. A., Bone, M., Robertson, H., Hudson, M., & Jones, D. E. J. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.2.158 · Cited by 51
Modest, D. P., Schulz, C. U., von Weikersthal, L. F., Quietzsch, D., von Einem, J. C., Schalhorn, A., Vehling‐Kaiser, U., Laubender, R. P., Giessen, C. A., Stintzing, S., et al. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000041 · Cited by 48
Racial disparities in advanced-stage colorectal cancer survival
Wallace, K., Hill, E. G., Lewin, D., Williamson, G., Oppenheimer, S., Ford, M. E., Wargovich, M. J., Berger, F. G., Bolick, S., Thomas, M. B., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-012-0133-5 · Cited by 47
Ahmadi, O., Stringer, M. D., Black, M. A., & McCall, J. L. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23848 · Cited by 41
Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations
Ogura, T., Kakuta, M., Yatsuoka, T., Nishimura, Y., Sakamoto, H., Yamaguchi, K., Tanabe, M., Tanaka, Y., & Akagi, K. (2014) · Oncology Reports · doi:10.3892/or.2014.3165 · Cited by 41
Katkoori, V. R., Shanmugam, C., Jia, X., Vitta, S. P., Sthanam, M., Callens, T., Messiaen, L. M., Chen, D., Zhang, B., Bumpers, H. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030020 · Cited by 33
Ishihara, S., Nishikawa, T., Tanaka, T., Tanaka, J., Kiyomatsu, T., Kawai, K., Hata, K., Nozawa, H., Kanazawa, T., Kazama, S., et al. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.07.270 · Cited by 32
Cohen, S. A., Wu, C., Yu, M., Gourgioti, G., Wirtz, R., Raptou, G., Gkakou, C., Kotoula, V., Pentheroudakis, G. E., Papaxoinis, G., et al. (2015) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2015.10.005 · Cited by 30
Survival After Resection of Colorectal Cancer Based on Anatomical Segment of Involvement
Bhangu, A. A., Kiran, R. P., Slesser, A. A. P., Fitzgerald, J. E. F., Brown, G. M., & Tekkis, P. P. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3104-5 · Cited by 29
Clinicopathologic Features and Outcome of Young Adults With Stage IV Colorectal Cancer
Hawk, N. N., Long, T., Imam, M., Mathew, B. M., Kim, S., Chen, Z., Goodman, M. G., Sullivan, P. S., Brutcher, E., Kauh, J. S. W., et al. (2014) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000437899.28701.03 · Cited by 26
Pentheroudakis, G. E., Raptou, G., Kotoula, V., Wirtz, R. M., Vrettou, E., Karavasilis, V., Gourgioti, G., Gakou, C., Syrigos, K. N., Bournakis, E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124612 · Cited by 23
Surveillance for early stages of colon cancer: potentials for optimizing follow-up protocols
Gilardoni, E., Bernasconi, D. P., Poli, S., Garancini, M., Luperto, M., Zucchini, N., Bovo, G., Totis, M., Bugatti, A., & Gianotti, L. V. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0674-7 · Cited by 22
Survival of distinct Asian groups among colorectal cancer cases in California
Le, H. V., Ziogas, A., Taylor, T. H., Lipkin, S. M., & Zell, J. A. (2008) · Cancer · doi:10.1002/cncr.24034 · Cited by 22
Deschoolmeester, V., Damme, N. V., Baay, M. F. D., Claes, K., Marck, E. V., Baert, F. J., Wuyts, W. A., Cabooter, M., Weyler, J., Vermeulen, P. B., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.043 · Cited by 20
Prognostic factors in sporadic colon cancer with high-level microsatellite instability
Oh, B. Y., Huh, J. W., Park, Y. A., Cho, Y. B., Yun, S. H., Kim, H. C., Lee, W. Y., & Chun, H.-K. (2016) · Surgery · doi:10.1016/j.surg.2015.11.028 · Cited by 16
Survival analysis for colon subsite and rectal cancers: Experience from a single surgeon
Lee, I., Baek, S., Kim, H., Jo, H.-J., Oh, N., & Ko, S. (2015) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.15019 · Cited by 4
Cited by
Colorectal cancer statistics, 2017
Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R. G. S., Barzi, A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21395 · Cited by 3,806
Colorectal cancer statistics, 2023
Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21772 · Cited by 3,733
Arnold, D., Lueza, B., Douillard, J.-Y., Peeters, M., Lenz, H.-J., Venook, A., Heinemann, V., Van Cutsem, E., Pignon, J.-P., Tabernero, J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx175 · Cited by 838
Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
Baran, B., Mert Ozupek, N., Yerli Tetik, N., Acar, E., Bekcioglu, O., & Baskin, Y. (2018) · Gastroenterology Research · doi:10.14740/gr1062w · Cited by 553
Wasan, H. S., Gibbs, P., Sharma, N. K., Taieb, J., Heinemann, V., Ricke, J., Peeters, M., Findlay, M., Weaver, A., Mills, J., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30457-6 · Cited by 403
Metadata
- Authors
- Petrelli, F., Tomasello, G., Borgonovo, K., Ghidini, M., Turati, L., Dallera, P., Passalacqua, R., Sgroi, G., & Barni, S.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-02-01
- Volume
- 3
- Issue
- 2
- Pages
- 211
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2543412381
- Cited by
- 729
- References
- 76
- FWCI
- 31.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.